Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
Conditions
- Non-small Cell Lung Cancer
- Vomiting
- Nausea
- Emesis
Interventions
- DRUG: FOSAPREPITANT (Emend)
- DRUG: Placebo
Sponsor
Ajeet Gajra
Collaborators